InvestorsHub Logo
Followers 1520
Posts 88995
Boards Moderated 5
Alias Born 05/09/2004

Re: None

Thursday, 12/27/2018 10:14:36 AM

Thursday, December 27, 2018 10:14:36 AM

Post# of 241
"On December 20, 2018, Adial Pharmaceuticals, Inc. (the “Company”), issued 162,500 shares of its common stock following its receipt on December 19, 2018 of a conversion notice from the holder of an outstanding convertible note in the principal amount of $325,000, thereupon retiring all outstanding debt instruments.

The Company issued the shares of common stock upon conversion of the convertible note to the noteholder in reliance on the exemption from registration provided for under Section 3(a)(9) of the Securities Act of 1933, as amended, as the issuance was made to an existing security holder, there was no additional consideration paid for the common stock and no commission or other remuneration was paid."

https://ih.advfn.com/stock-market/NASDAQ/adial-pharmaceuticals-inc-ADIL/stock-news/78948536/current-report-filing-8-k
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADIL News